106 related articles for article (PubMed ID: 10598062)
21. [End phase challenges of poliomyelitis eradication programme realization].
Jarzabek Z
Przegl Epidemiol; 2005; 59(1):59-68. PubMed ID: 16013411
[TBL] [Abstract][Full Text] [Related]
22. [Testing a virostatic agent in persons vaccinated with poliomyelitis viruses].
Alexander M; Eggert E
Zentralbl Bakteriol Orig; 1964 Jun; 193(1):40-7. PubMed ID: 5319065
[No Abstract] [Full Text] [Related]
23. Polio vaccination.
Eggers HJ; Mertens T
JAMA; 1987 Jul; 258(3):322-3. PubMed ID: 3599319
[No Abstract] [Full Text] [Related]
24. Analysis of reversions in the 5'-untranslated region of attenuated poliovirus after sequential administration of inactivated and oral poliovirus vaccines.
Laassri M; Lottenbach K; Belshe R; Rennels M; Plotkin S; Chumakov K
J Infect Dis; 2006 May; 193(10):1344-9. PubMed ID: 16619180
[TBL] [Abstract][Full Text] [Related]
25. Poliovaccination in the Gambia.
Geffen T
Lancet; 1987 Aug; 2(8557):511-2. PubMed ID: 2887803
[No Abstract] [Full Text] [Related]
26. Safety and immunogenicity of a booster dose of inactivated poliovirus vaccine produced in vero-cells.
Haastrup E; Thierry-Carstensen B; Jensen AM; Stellfeld M; Heilmann C
Vaccine; 2004 Feb; 22(8):958-62. PubMed ID: 15161072
[TBL] [Abstract][Full Text] [Related]
27. 1,25-dihydroxyvitamin d3 enhances systemic and mucosal immune responses to inactivated poliovirus vaccine in mice.
Ivanov AP; Dragunsky EM; Chumakov KM
J Infect Dis; 2006 Feb; 193(4):598-600. PubMed ID: 16425140
[TBL] [Abstract][Full Text] [Related]
28. The maintaining of the active laboratory-based surveillance of the acute flaccid paralysis (AFP) cases in Romania in the framework of the strategic plan of the global polio eradication initiative.
Băicuş A; Persu A; Combiescu M; Aubert-Combiescu A
Roum Arch Microbiol Immunol; 2007; 66(1-2):44-50. PubMed ID: 18928063
[TBL] [Abstract][Full Text] [Related]
29. Antiviral therapy for neurological manifestations of enterovirus 71 infection.
Arya SC
Clin Infect Dis; 2000 Jun; 30(6):988. PubMed ID: 10880332
[No Abstract] [Full Text] [Related]
30. [Worldwide eradication of poliomyelitis].
Rasch G; Schreier E; Kiehl W; Kurth R
Wien Klin Wochenschr; 2001 Oct; 113(20-21):839-45. PubMed ID: 11732120
[TBL] [Abstract][Full Text] [Related]
31. [Effective antiviral treatment of chronic poliomyelitis in adults].
Lobzin VS; Golovkin VI; Nemchenko NS
Sov Med; 1981; (3):104-8. PubMed ID: 6166054
[No Abstract] [Full Text] [Related]
32. Polio eradication: the OPV paradox.
Dowdle WR; De Gourville E; Kew OM; Pallansch MA; Wood DJ
Rev Med Virol; 2003; 13(5):277-91. PubMed ID: 12931339
[TBL] [Abstract][Full Text] [Related]
33. [Action in vivo of some thiocarbanilides on the vaccinia virus and on experimental poliomyelitis].
Nguyên Dat-Xuong ; Martin du Pan R; Gazave JM; Nguyên-Hoang Nam ; Hasle B
Ann Inst Pasteur (Paris); 1965 Oct; 109(4):600-4. PubMed ID: 5848621
[No Abstract] [Full Text] [Related]
34. Persistence of vaccine-derived polioviruses among immunodeficient persons with vaccine-associated paralytic poliomyelitis.
Khetsuriani N; Prevots DR; Quick L; Elder ME; Pallansch M; Kew O; Sutter RW
J Infect Dis; 2003 Dec; 188(12):1845-52. PubMed ID: 14673763
[TBL] [Abstract][Full Text] [Related]
35. The risks of stopping vaccination: perspectives from the developing world.
Schoub BD
Bull World Health Organ; 2000; 78(3):360-1. PubMed ID: 10812734
[No Abstract] [Full Text] [Related]
36. Gaps in our knowledge about transmission of vaccine-derived polioviruses.
Fine PE
Bull World Health Organ; 2000; 78(3):358-9. PubMed ID: 10812732
[TBL] [Abstract][Full Text] [Related]
37. World wide experience with inactivated poliovirus vaccine.
Bonnet MC; Dutta A
Vaccine; 2008 Sep; 26(39):4978-83. PubMed ID: 18680777
[TBL] [Abstract][Full Text] [Related]
38. Epidemiology of poliomyelitis--options and update.
Dutta A
Vaccine; 2008 Oct; 26(45):5767-73. PubMed ID: 18755232
[TBL] [Abstract][Full Text] [Related]
39. A population-based, postlicensure evaluation of the safety of a combination diphtheria, tetanus, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine in a large managed care organization.
Zangwill KM; Eriksen E; Lee M; Lee J; Marcy SM; Friedland LR; Weston W; Howe B; Ward JI
Pediatrics; 2008 Dec; 122(6):e1179-85. PubMed ID: 19047220
[TBL] [Abstract][Full Text] [Related]
40. Three cases of paralytic poliomyelitis associated with type 3 vaccine poliovirus strains in Bulgaria.
Korsun N; Kojouharova M; Vladimirova N; Fiore L; Litvinenko I; Buttinelli G; Fiore S; Voynova-Georgieva V; Mladenova Z; Georgieva D
J Med Virol; 2009 Sep; 81(9):1661-7. PubMed ID: 19626606
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
